FAM treatment for new onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation

Bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic cell transplantation (HCT) is associated with high mortality. Purpose: We hypothesized that FAM (inhaled Fluticasone, Azithromycin, and Montelukast) with a brief steroid pulse could avert progression of new-onset BOS. Experimenta...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biol Blood Marrow Transplant
Главные авторы: Williams, Kirsten M., Cheng, Guang-Shing, Pusic, Iskra, Jagasia, Madan, Burns, Linda, Ho, Vincent T., Pidala, Joseph, Palmer, Jeanne, Johnston, Laura, Mayer, Sebastian, Chien, Jason W., Jacobsohn, David A., Pavletic, Steven Z., Martin, Paul J., Storer, Barry E., Inamoto, Yoshihiro, Chai, Xiaoyu, Flowers, Mary E.D., Lee, Stephanie J.
Формат: Artigo
Язык:Inglês
Опубликовано: 2015
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4801753/
https://ncbi.nlm.nih.gov/pubmed/26475726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.10.009
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы